Nobel Biocare has launched its first official apps in the Apple App Store to provide interested dental professionals the possibility to view the latest information and innovations from Nobel Biocare. The new apps are built around the new publication, Nobel Biocare News, which launched in November of 2011.
With these new apps, Nobel Biocare News readers can now experience the full print version adapted for both the iPad and iPhone with additional bonus content. Future editions will contain extra or expanded articles, extended selections of images as well as related videos which will only be available on the apps and online at www.nobelbiocare.com/newsletter.
Going forward, these new apps will also feature various information sections that will push the latest company news, training and event information to readers. Additional apps for other portable devices will follow soon. Nobel Biocare News is a newsletter for the global dental community. The publication itself is a re-launch of the very successful Nobelpharma News (1987-1996). Nobel Biocare News will serve as a flagship communication tool for Nobel Biocare to both its customers and the outside dental industry. The newsletter will be a key platform for highlighting dental innovations, products and solutions, clinical expertise, customer experiences and patient outcomes. It is intended to promote a sense of community among its readers around the world by reporting on innovative and advanced restorative dentistry from their perspective.
Visit www.nobelbiocare.com/newsletter or search “Nobel Biocare News” in the Apple App Store to get the latest dental industry news.
Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions. As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions from tooth to root, for single tooth to fully edentulous indications. The solutions portfolio covers dental implants (including the key brands NobelActive™, Brånemark System® and NobelReplace®, individualized prosthetics and equipment (NobelProcera™ guided surgery solutions and biomaterials). Nobel Biocare has over 2’400 employees and recorded revenue of EUR 569.2 million in 2011. The company is headquartered in Zurich, Switzerland. Production takes place at seven sites located in Canada, Israel, Japan, Sweden, and the US. Nobel Biocare has 34 direct sales organizations.